AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

SKIN · NASDAQ · Medical - Specialties

SkinHealth Systems

Builds professional aesthetic treatments around devices and proprietary consumables.

$0.6850

After-hours close+0.00 (+0.01%)

At close$0.6849(−0.95%)

Something off on this page? Send us feedback.

Profile

The Beauty Health CompanySKINHealth Care

Provides professional aesthetic devices and proprietary consumables centered on Hydrafacial, alongside SkinStylus microneedling and HydraScalp with Keravive. The device-and-consumables platform reaches providers through an omnichannel network and pairs its offerings with clinical validation.

Built around Hydrafacial, a professional hydradermabrasion treatment that uses a patented delivery system to cleanse, extract, and hydrate skin with proprietary solutions and serums. The portfolio also includes SkinStylus microneedling and HydraScalp with Keravive for scalp health.

Designs, develops, manufactures, markets, and sells aesthetic technologies and products through an omnichannel provider network. Its stated model combines advanced device technology, proprietary consumables, and clinical validation across a multi-brand treatment platform.

Hydrafacial remains the flagship brand. The operating lineage traces to Hydrafacial's creation of the hydradermabrasion category in 1997. The listed parent adopted the SkinHealth Systems name while retaining Nasdaq ticker SKIN.

Company facts

CEOPedro Malha

ListedMay 5, 2021

ExchangeNASDAQ

HeadquartersLong Beach, CA

CountryUnited States

Employees613

CIK0001818093

ISINUS88331L1089

Key statistics

Market cap$88.8M

EPS (ttm)−$0.2236

P/E (ttm)−3.06

ROE-47.8%

P/B1.60

P/S0.3061

Dividend yield—

Beta1.28vs XLV 0.44

Year to date −51.1% · Average volume (30d) 568.1K

Analysts

Price target, next 12 months$1.50+117.4%Median of 14 analysts · vs the Aug 28 close

ConsensusHold4 of 14 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $0.6900

High$2.00+189.9%

Median$1.50+117.4%

Low$1.00+44.9%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Rating	Prior target	Target
May 20, 2026	Roth Capital	Reiterate	Buy	$3.50	$2
May 1, 2026	Canaccord Genuity	Reiterate	Hold	$1.25	$1
Jan 14, 2026	Jefferies	Target			$1.60
Sep 19, 2025	Roth Capital	Target			$3.50

Earnings

EPS

Estimate−$0.07

ReportedDue Nov 5, 2026

Revenue

Estimate$67.8M

ReportedDue Nov 5, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 6, 2026Q2 FY26	−$0.03	−$0.02	+20.0%	$74.5M	$72.1M	−3.2%	−13.91%
May 7, 2026Q1 FY26	−$0.09	−$0.05	+44.4%	$66.3M	$64.9M	−2.1%	−36.26%
Mar 12, 2026Q4 FY25	−$0.07	−$0.06	+14.3%	$78.2M	$82.4M	+5.4%	+19.81%
Nov 6, 2025Q3 FY25	−$0.08	−$0.09	−12.5%	$78.1M	$70.7M	−9.5%	+8.53%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$69.6M	$78.2M	$70.7M	$82.4M	$64.9M	$72.1M
Gross profit	$48.6M	$49.1M	$45.6M	$53.0M	$44.4M	$49.3M
Operating income	−$12.0M	−$2.7M	−$6.2M	$162.0K	−$1.8M	$3.6M
Net income	−$10.1M	$19.7M	−$11.0M	−$8.1M	−$6.6M	−$2.7M
Diluted EPS	−$0.08	$0.03	−$0.09	−$0.06	−$0.05	−$0.02
Gross margin	69.8%	62.8%	64.6%	64.4%	68.4%	68.4%
Operating margin	-17.3%	-3.5%	-8.8%	0.2%	-2.8%	5.0%

Fiscal years (4-quarter sums)FY21 $260.1M · FY22 $365.9M · FY23 $398.0M · FY24 $334.3M · FY25 $300.8M

Revenue by product · Q2 FY26

Consumables$53.9M · 75%

Delivery Systems$18.3M · 25%

Revenue by geography · Q2 FY26

Americas$49.9M · 69%

EMEA$14.9M · 21%

Asia Pacific$7.3M · 10%

Balance sheet, Jun 30, 2026Cash & short-term investments $206.1M · Total debt $367.1M · Total assets $486.6M · Shareholders' equity $55.6M

Dividends

No dividends on record.

Ownership

Institutions 60.38%78.26M sharesInsiders 15.68%20.32M sharesOther 23.94%31.02M shares

Shares outstanding 129.60M · Float 79.66M · 61.5% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Linden Capital III LLC	33.36M	25.74%	13D	May 11, 2026
Capricorn Fund Managers Ltd	19.40M	14.97%	13F	Apr 24, 2026
Abigail P. Johnson	18.60M	15.00%	13D/G	Nov 12, 2024
FMR LLC	17.18M	13.40%	13G	May 6, 2026
BlackRock, Inc.	7.36M	5.68%	13F	May 13, 2026

Insider tradesForm 4

No open-market trades in the last 12 months.